ATE417125T1 - Diagnose von einer klinischen infektion einer wunde - Google Patents

Diagnose von einer klinischen infektion einer wunde

Info

Publication number
ATE417125T1
ATE417125T1 AT02774985T AT02774985T ATE417125T1 AT E417125 T1 ATE417125 T1 AT E417125T1 AT 02774985 T AT02774985 T AT 02774985T AT 02774985 T AT02774985 T AT 02774985T AT E417125 T1 ATE417125 T1 AT E417125T1
Authority
AT
Austria
Prior art keywords
wound
clinical infection
protease
marker
diagnosis
Prior art date
Application number
AT02774985T
Other languages
English (en)
Inventor
Breda Cullen
Original Assignee
Johnson & Johnson Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Medical Ltd filed Critical Johnson & Johnson Medical Ltd
Application granted granted Critical
Publication of ATE417125T1 publication Critical patent/ATE417125T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Winding, Rewinding, Material Storage Devices (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
AT02774985T 2001-11-05 2002-11-05 Diagnose von einer klinischen infektion einer wunde ATE417125T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0126534A GB2381452B (en) 2001-11-05 2001-11-05 Wound monitoring

Publications (1)

Publication Number Publication Date
ATE417125T1 true ATE417125T1 (de) 2008-12-15

Family

ID=9925173

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02774985T ATE417125T1 (de) 2001-11-05 2002-11-05 Diagnose von einer klinischen infektion einer wunde

Country Status (8)

Country Link
US (1) US7794925B2 (de)
EP (1) EP1453970B1 (de)
AT (1) ATE417125T1 (de)
AU (1) AU2002341191A1 (de)
DE (1) DE60230320D1 (de)
ES (1) ES2316621T3 (de)
GB (1) GB2381452B (de)
WO (1) WO2003040406A2 (de)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
DE10057832C1 (de) 2000-11-21 2002-02-21 Hartmann Paul Ag Blutanalysegerät
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
ES2336081T3 (es) 2001-06-12 2010-04-08 Pelikan Technologies Inc. Dispositivo de puncion de auto-optimizacion con medios de adaptacion a variaciones temporales en las propiedades cutaneas.
CA2448681C (en) 2001-06-12 2014-09-09 Pelikan Technologies, Inc. Integrated blood sampling analysis system with multi-use sampling module
AU2002312521A1 (en) 2001-06-12 2002-12-23 Pelikan Technologies, Inc. Blood sampling apparatus and method
ATE497731T1 (de) 2001-06-12 2011-02-15 Pelikan Technologies Inc Gerät zur erhöhung der erfolgsrate im hinblick auf die durch einen fingerstich erhaltene blutausbeute
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US7041068B2 (en) 2001-06-12 2006-05-09 Pelikan Technologies, Inc. Sampling module device and method
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
ATE485766T1 (de) 2001-06-12 2010-11-15 Pelikan Technologies Inc Elektrisches betätigungselement für eine lanzette
AU2002348683A1 (en) 2001-06-12 2002-12-23 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7344894B2 (en) 2001-10-16 2008-03-18 Agilent Technologies, Inc. Thermal regulation of fluidic samples within a diagnostic cartridge
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7141058B2 (en) 2002-04-19 2006-11-28 Pelikan Technologies, Inc. Method and apparatus for a body fluid sampling device using illumination
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7563232B2 (en) 2002-04-19 2009-07-21 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7410468B2 (en) 2002-04-19 2008-08-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7481776B2 (en) 2002-04-19 2009-01-27 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7524293B2 (en) 2002-04-19 2009-04-28 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7374544B2 (en) 2002-04-19 2008-05-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US7582099B2 (en) 2002-04-19 2009-09-01 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US7175642B2 (en) 2002-04-19 2007-02-13 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
EP1633235B1 (de) 2003-06-06 2014-05-21 Sanofi-Aventis Deutschland GmbH Gerät für die entnahme von körperflüssigkeiten und analyten-nachweis
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US7604592B2 (en) 2003-06-13 2009-10-20 Pelikan Technologies, Inc. Method and apparatus for a point of care device
EP1671096A4 (de) 2003-09-29 2009-09-16 Pelikan Technologies Inc Verfahren und apparatur für eine verbesserte probeneinfangvorrichtung
US9351680B2 (en) 2003-10-14 2016-05-31 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a variable user interface
CN1902494B (zh) * 2003-11-03 2010-10-27 伊西康公司 用于检测广谱细菌的方法、肽和生物传感器
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
EP1706026B1 (de) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Verfahren und vorrichtung zur verbesserung der fluidströmung und der probennahme
WO2006011062A2 (en) 2004-05-20 2006-02-02 Albatros Technologies Gmbh & Co. Kg Printable hydrogel for biosensors
WO2005120365A1 (en) 2004-06-03 2005-12-22 Pelikan Technologies, Inc. Method and apparatus for a fluid sampling device
GB0413001D0 (en) * 2004-06-10 2004-07-14 Johnson & Johnson Medical Ltd Diagnostic and prognostic
EP1756298B1 (de) * 2004-06-11 2010-06-09 Systagenix Wound Management IP Co. BV. Wundinfektionsdiagnose und -prognose durch messung einer phospholipase a2 in wundflüssigkeit
GB2415039B (en) 2004-06-11 2008-11-12 Johnson & Johnson Medical Ltd Diagnosis and prognosis
GB2418145A (en) * 2004-09-17 2006-03-22 Ethicon Inc Wound treatment system
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
GB0520405D0 (en) * 2005-10-07 2005-11-16 Imp College Innovations Ltd Biological agents and method
CA2671872A1 (en) * 2006-12-07 2008-06-12 University Of Florida Research Foundation, Inc. Materials and methods for efficient and accurate detection of analytes
GB2447865A (en) 2007-03-30 2008-10-01 Ethicon Inc Diagnostic markers of wound infection
GB0806186D0 (en) * 2008-04-04 2008-05-14 Axis Shield Diagnostics Ltd Method
GB2459098A (en) * 2008-04-08 2009-10-14 Ethicon Inc Genetic markers of wound development
WO2009126900A1 (en) 2008-04-11 2009-10-15 Pelikan Technologies, Inc. Method and apparatus for analyte detecting device
CA3162577C (en) 2008-05-20 2023-09-26 University Health Network Device and method for fluorescence-based imaging and monitoring
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
AU2010251237B2 (en) * 2009-05-18 2015-12-10 Mega Patent Exploitation Gmbh Method for detecting a wound infection
CA2764775C (en) 2009-06-26 2019-02-26 University Of Florida Research Foundation, Inc. Rapid bed-side measurement of neutrophil elastase activity in biological fluids
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
EP2671081A2 (de) * 2011-01-31 2013-12-11 Systagenix Wound Management IP Co. BV. Wundprognose
GB201116523D0 (en) * 2011-09-23 2011-11-09 Systagenix Wound Man Ip Co Bv Wound prognosis
US9024751B2 (en) 2012-04-12 2015-05-05 Elwha Llc Dormant to active appurtenances for reporting information regarding wound dressings
US10130518B2 (en) 2012-04-12 2018-11-20 Elwha Llc Appurtenances including sensors for reporting information regarding wound dressings
US10226212B2 (en) 2012-04-12 2019-03-12 Elwha Llc Appurtenances to cavity wound dressings
US9084530B2 (en) 2012-04-12 2015-07-21 Elwha Llc Computational methods and systems for reporting information regarding appurtenances to wound dressings
US10265219B2 (en) 2012-04-12 2019-04-23 Elwha Llc Wound dressing monitoring systems including appurtenances for wound dressings
US10158928B2 (en) 2012-04-12 2018-12-18 Elwha Llc Appurtenances for reporting information regarding wound dressings
WO2016011534A1 (en) 2014-07-24 2016-01-28 University Health Network Collection and analysis of data for diagnostic purposes
SG11201808488XA (en) 2016-03-30 2018-10-30 Convatec Technologies Inc Detecting microbial infections in wounds
SG11201808528VA (en) 2016-03-30 2018-10-30 Convatec Technologies Inc Modified wound dressings
WO2017182765A1 (en) * 2016-04-18 2017-10-26 Swansea University Method of detecting bacterial infection in a biological sample
EP3901277A1 (de) 2020-04-24 2021-10-27 Paul Hartmann AG Verfahren und vorrichtung zur beurteilung des zustandes einer wunde eines patienten
EP3901276A1 (de) 2020-04-24 2021-10-27 Paul Hartmann AG Verfahren und vorrichtung zur beurteilung des zustandes einer wunde eines patienten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2323166B (en) 1997-03-12 2001-04-11 Johnson & Johnson Medical Method and apparatus for mapping the condition of a wound
AU743099B2 (en) 1997-06-09 2002-01-17 Systagenix Wound Management Ip Co. B.V. Novel impaired wound model
RU2146367C1 (ru) * 1997-07-22 2000-03-10 Гуменюк Сергей Евгеньевич Способ прогнозирования течения раневого процесса
US5912114A (en) * 1997-09-12 1999-06-15 Johnson & Johnson Medical, Inc. Wound diagnosis by quantitating cortisol in wound fluids
GB2340235A (en) 1998-08-05 2000-02-16 Johnson & Johnson Medical Ltd Monitoring bacterial contamination of a wound involving assay of adenosine triphosphate
EP1257826A2 (de) * 2000-02-10 2002-11-20 The Research Foundation Of State University Of New York Verfahren zum nachweis bakterieller reizungen bei chronischer lungenkrankheit

Also Published As

Publication number Publication date
US20050079542A1 (en) 2005-04-14
WO2003040406A2 (en) 2003-05-15
GB2381452A (en) 2003-05-07
US7794925B2 (en) 2010-09-14
GB0126534D0 (en) 2002-01-02
ES2316621T3 (es) 2009-04-16
EP1453970B1 (de) 2008-12-10
WO2003040406A3 (en) 2003-10-16
AU2002341191A1 (en) 2003-05-19
GB2381452B (en) 2005-08-10
EP1453970A2 (de) 2004-09-08
DE60230320D1 (de) 2009-01-22

Similar Documents

Publication Publication Date Title
ATE417125T1 (de) Diagnose von einer klinischen infektion einer wunde
DK1421215T3 (da) Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA
JP2014503252A (ja) 感知パッチ用途
PT2073008E (pt) Métodos de imunoensaio melhorados
AU2003220041A8 (en) Apparatus and methods for analyte measurement and immunoassay
EP1316802A3 (de) Verfahren zur Analyse der Blutkoagluationsreaktion
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
ATE368229T1 (de) Diagnostischer test zur bestimmung der konzentration einer transienten proteolytischen aktivität in zusammengesetzten biologischen medien
ATE252238T1 (de) Methoden für die diagnose von allergischen atemwegsaspergillosen
ATE294392T1 (de) Reagenz zur bestimmung von blutplättchen- mikroteilchen
DE60234821D1 (de) Messverfahren für vollblut
GB0420774D0 (en) Wound treatment system
ATE356667T1 (de) Analysegerät für biologische flüssigkeiten
ATE272214T1 (de) Verfahren zur diagnose von sepsis unter bestimmung von s100b
WO2006113210A3 (en) Diagnostic multimarker serological profiling
ATE272215T1 (de) Verfahren zur diagnose von sepsis unter bestimmung von ca 19-9
DE50313393D1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
ATE355389T1 (de) Verfahren zur diagnose von schizophrenie
DE50105971D1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 125
ATE431556T1 (de) Bestimmung von kurzkettiger srl- alkoholdehydrogenase (dhrs4) als biomarker für entzündungen und infektionen
BR0317404A (pt) Variantes do fator xiia
DK1393078T3 (da) Fremgangsmåder til diagnosticering in vitro eller til overvågning af en sygdom involverende en inflammatorisk reaktion
ATE472611T1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
ATE485515T1 (de) Verfahren zur diagnose einer person mit multipler sklerose
DE60034660D1 (de) Monoklonaler antikörper gegen protein c inhibitor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties